Page 3 - Ioscience News Today

Dublin, Aug. 30, 2023 (GLOBE NEWSWIRE) -- The "Plant Biotechnology Equipment - Global Strategic Business Report" report has been added to ...

Rua Bioscience ( NZSE:RUA ) Full Year 2023 Results Key Financial Results Net loss: NZ$5.96m (loss narrowed by 31% from...

Content by MilliporeSigma. This first-generation Filipino American is no stranger to change. However, it wasn’t until his accident and when he began accepting his “new normal” that things truly began

SK bioscience said Thursday it has reached a deal with Vaxxas, an Australian biotechnology company, to jointly develop a new patch-type typhoid vaccine.

SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that its board of directors has decided to make an equity investment in Novavax, a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, securing 6.5 million shares of common stock through a private placement.

AUSTIN, Texas, July 31, 2023--Pattern Bioscience was named the winner of the 2023 Disruptive Technology Award from the Association for Diagnostics & Laboratory Medicine

SK Bioscience on Friday reported its second-quarter net loss of 16 billion won ($12.5 million), swinging from a profit of 46.1 billion won a year earlier.

SK Bioscience on Friday reported its second-quarter net loss of 16 billion won ($12.5 million), swinging from a profit of 46.1 billion won a year earlier.

By Daniella Parra Octave Bioscience said it secured a $30 million extension to its Series B funding round. The investment, led by Novartis, Hikma Ventures and Intermountain Ventures, will accelerate commercialization of their precision care solution for multiple sclerosis (MS) and other neurodegenerative diseases, the company said in a statement. “The strength and breadth of […]

Joint study by University of Science and Technology, Chinese University shows SARS-CoV-2 virus can significantly disrupt development of placenta in pregnant women.